Article Summary
A new study suggests that cutting-edge GLP-1 weight-loss drugs can help lower cancer risk beyond the benefits from losing excess pounds. The research found that first-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of certain cancers. These drugs work by mimicking the functions of the GLP-1 hormone, which helps regulate blood sugar levels and appetite.
What This Means for You
- If you are overweight or obese, taking GLP-1 weight-loss drugs may help reduce your risk of developing certain cancers.
- Even if you are already at a healthy weight, these drugs may still offer some cancer protection.
- It’s important to note that GLP-1 drugs are not a substitute for a healthy lifestyle. Regular exercise, a balanced diet, and avoiding tobacco and excessive alcohol are still essential for overall health and cancer prevention.
- Further research is needed to confirm these findings and to determine which cancers may be most affected by GLP-1 drugs.
Original Post
Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of… Read more
Key Terms
- GLP-1 weight-loss drugs: a type of medication that helps regulate blood sugar levels and appetite
- First-generation GLP-1 drugs: medications such as liraglutide (Saxenda) and exenatide (Byetta)
- Cancer risk: the likelihood of developing cancer
- Obesity: a condition characterized by having excess body fat
- Cancer prevention: actions taken to reduce the risk of developing cancer
ORIGINAL SOURCE:
Source link
